Acromegaly and gigantism are the same hormone problem—too much growth hormone (GH)—but Step questions love to test when it happens. If you can quickly anchor it to epiphyseal plates, you’ll never mix them up again.
The core visual hack (one image in your head)
“Open plates = tall. Closed plates = broad.”
Picture two doorways:
- Open doorway (open epiphyseal plates) → you can keep walking “up” → gets taller = gigantism
- Closed doorway (closed epiphyseal plates) → can’t go “up,” so you expand “out” → bigger hands/feet/jaw = acromegaly
One-liner:
Gigantism = GH excess before epiphyseal closure → increased height.
Acromegaly = GH excess after epiphyseal closure → enlarged extremities + facial features.
Acromegaly vs Gigantism: rapid comparison table
| Feature | Gigantism | Acromegaly |
|---|---|---|
| Timing | Before epiphyseal closure (kids/adolescents) | After epiphyseal closure (adults) |
| Height | Very tall (↑ linear growth) | Usually normal height |
| Hands/feet | Big (can happen) | Big (classic: ring/shoe size increases) |
| Face/jaw | Can develop | Coarse facial features, prognathism, enlarged nose/lips |
| Mechanism | GH excess → ↑ IGF-1 → growth | GH excess → ↑ IGF-1 → soft tissue + bone thickening |
| Classic cause | Pituitary somatotroph adenoma (most common) | Pituitary somatotroph adenoma (most common) |
High-yield path & physiology (what Step expects)
The key axis
- Hypothalamus
- GHRH stimulates GH release
- Somatostatin inhibits GH release
- Anterior pituitary (somatotrophs) → secretes GH
- Liver (and other tissues) → GH stimulates IGF-1 production → mediates many growth effects
Why IGF-1 is the test’s favorite lab
- IGF-1 levels are more stable than GH (GH is pulsatile)
- So screening/monitoring is typically IGF-1
Presentation pearls you can recognize in a vignette
Acromegaly “classic clues”
- Enlarged hands/feet (ring no longer fits, shoe size increased)
- Coarse facial features, macroglossia, prognathism
- Hyperhidrosis, oily skin
- Arthralgias, carpal tunnel syndrome
- Organomegaly (e.g., cardiomegaly)
- Headache + bitemporal hemianopsia (mass effect on optic chiasm from pituitary macroadenoma)
Metabolic associations (high yield)
- GH is anti-insulin → insulin resistance, hyperglycemia/diabetes
- Cardiovascular complications drive morbidity: HTN, cardiomyopathy, arrhythmias
Diagnosis: the two-step that gets tested
1) Screen/confirm with IGF-1
- Elevated IGF-1 supports GH excess
2) Confirm with oral glucose suppression test
- Normal physiology: glucose load → suppresses GH
- Acromegaly/gigantism: GH fails to suppress after oral glucose
Then:
- Pituitary MRI to localize an adenoma
USMLE-style line:
“If GH doesn’t go down after oral glucose, it’s acromegaly/gigantism.”
Treatment snapshot (Step-level)
- Transsphenoidal surgery is typical first-line for pituitary adenoma
- Meds (esp. if persistent or not surgical candidate):
- Octreotide (somatostatin analog) ↓ GH secretion
- Pegvisomant (GH receptor antagonist) ↓ IGF-1 effects
- Cabergoline (dopamine agonist) can help in some cases
Micro-mnemonics you can reuse on test day
“GIGA = Growth Increases Greatly (in height)”
- Gigantism = height story + child/adolescent timing
“ACRO = Acral parts grow (hands/feet/jaw)”
- Acromegaly = acral enlargement + adult timing
Ultra-quick recap (shareable)
- Same disease mechanism (↑ GH → ↑ IGF-1), different timing.
- Before plates close → gigantism (tall).
- After plates close → acromegaly (wide: hands/feet/jaw + coarse face).
- Dx: ↑ IGF-1 + failure of GH suppression with oral glucose.